Sequential hormonochemotherapy in advanced breast cancer

av Hart, Lowell L
Publicerad 1988

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

av Berdeja, Jesus G., Hart, Lowell L., Mace, Joseph R., Arrowsmith, Edward R., Essell, James H., Owera, Rami S., Hainsworth, John D., Flinn, Ian W.
I publikationen Haematologica (2015)

A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose‐expansion coh...

av Berdeja, Jesus G., Gregory, Tara K., Faber, Edward A., Hart, Lowell L., Mace, Joseph R., Arrowsmith, Edward R., Flinn, Ian W., Matous, Jeffrey V.
I publikationen Am J Hematol (2021)

Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours

av Mahalingam, Devalingam, Patel, Manish R., Sachdev, Jasgit C., Hart, Lowell L., Halama, Niels, Ramanathan, Ramesh K., Sarantopoulos, John, Völkel, Dirk, Youssef, Ashraf, de Jong, Floris A., Tsimberidou, Apostolia Maria
I publikationen Br J Clin Pharmacol (2020)

Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial

av O’Shaughnessy, Joyce, Petrakova, Katarina, Sonke, Gabe S., Conte, Pierfranco, Arteaga, Carlos L., Cameron, David A., Hart, Lowell L., Villanueva, Cristian, Jakobsen, Erik, Beck, Joseph T., Lindquist, Deborah, Souami, Farida, Mondal, Shoubhik, Germa, Caroline, Hortobagyi, Gabriel N.
I publikationen Breast Cancer Res Treat (2017)

A randomized, placebo‐controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild‐type...

av Eng, Cathy, Bessudo, Alberto, Hart, Lowell L., Severtsev, Aleksey, Gladkov, Oleg, Müller, Lothar, Kopp, Mikhail V., Vladimirov, Vladimir, Langdon, Robert, Kotiv, Bogdan, Barni, Sandro, Hsu, Ching, Bolotin, Ellen, von Roemeling, Reinhard, Schwartz, Brian, Bendell, Johanna C.
I publikationen Int J Cancer (2016)

A Phase II Randomized Trial (GO27827) of First‐Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer

av Bendell, Johanna C., Hochster, Howard, Hart, Lowell L., Firdaus, Irfan, Mace, Joseph R., McFarlane, Joshua J., Kozloff, Mark, Catenacci, Daniel, Hsu, Jessie J., Hack, Stephen P., Shames, David S., Phan, See‐Chun, Koeppen, Hartmut, Cohn, Allen L.
I publikationen Oncologist (2017)

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

av Hart, Lowell L., Ferrarotto, Renata, Andric, Zoran G., Beck, J. Thaddeus, Subramanian, Janakiraman, Radosavljevic, Davorin Z., Zaric, Bojan, Hanna, Wahid T., Aljumaily, Raid, Owonikoko, Taofeek K., Verhoeven, Didier, Xiao, Jie, Morris, Shannon R., Antal, Joyce M., Hussein, Maen A.
I publikationen Adv Ther (2020)

A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma

av Ross, Helen J., Hart, Lowell L., Swanson, Paul M., Rarick, Mark U., Figlin, Robert A., Jacobs, Andrew D., McCune, David E., Rosenberg, Arthur H., Baron, Ari D., Grove, Laurie E., Thorn, Michael D., Miller, Dennis M., Drachman, Jonathan G., Rudin, Charles M.
Publicerad 2006

Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial

av Sonke, Gabe S., Hart, Lowell L., Campone, Mario, Erdkamp, Frans, Janni, Wolfgang, Verma, Sunil, Villanueva, Cristian, Jakobsen, Erik, Alba, Emilio, Wist, Erik, Favret, Anne M., Bachelot, Thomas, Hegg, Roberto, Wheatley-Price, Paul, Souami, Farida, Sutradhar, Santosh, Miller, Michelle, Germa, Caroline, Burris, Howard A.
I publikationen Breast Cancer Res Treat (2017)

Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2...

av Autio, Karen A., Dreicer, Robert, Anderson, Justine, Garcia, Jorge A., Alva, Ajjai, Hart, Lowell L., Milowsky, Matthew I., Posadas, Edwin M., Ryan, Charles J., Graf, Ryon P., Dittamore, Ryan, Schreiber, Nicole A., Summa, Jason M., Youssoufian, Hagop, Morris, Michael J., Scher, Howard I.
I publikationen JAMA Oncol (2018)

Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2

av Gnant, Michael, Baselga, Jose, Rugo, Hope S., Noguchi, Shinzaburo, Burris, Howard A., Piccart, Martine, Hortobagyi, Gabriel N., Eakle, Janice, Mukai, Hirofumi, Iwata, Hiroji, Geberth, Matthias, Hart, Lowell L., Hadji, Peyman, El-Hashimy, Mona, Rao, Shantha, Taran, Tetiana, Sahmoud, Tarek, Lebwohl, David, Campone, Mario, Pritchard, Kathleen I.
I publikationen J Natl Cancer Inst (2013)

Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes

av Grivas, Petros, Mortazavi, Amir, Picus, Joel, Hahn, Noah M., Milowsky, Matthew I., Hart, Lowell L., Alva, Ajjai, Bellmunt, Joaquim, Pal, Sumanta K., Bambury, Richard M., O’Donnell, Peter H., Gupta, Sumati, Guancial, Elizabeth A., Sonpavde, Guru P., Faltaos, Demiana, Potvin, Diane, Christensen, James G., Chao, Richard C., Rosenberg, Jonathan E.
I publikationen Cancer (2018)

Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients

av Paoletti, Costanza, Regan, Meredith M., Niman, Samuel M., Dolce, Emily M., Darga, Elizabeth P., Liu, Minetta C., Marcom, P. Kelly, Hart, Lowell L., Smith, John W., Tedesco, Karen L., Amir, Eitan, Krop, Ian E., DeMichele, Angela M., Goodwin, Pamela J., Block, Margaret, Aung, Kimberly, Brown, Martha E., McCormack, Robert T., Hayes, Daniel F.
I publikationen NPJ Breast Cancer (2021)